Industry Research Reports

Home > Reports > Chemical & Material > Cosmetic Grade Nicotinamide Mononucleotide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Cosmetic Grade Nicotinamide Mononucleotide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-11-25

Pages: 100 Pages

Report ld: 5489530

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Cosmetic Grade Nicotinamide Mononucleotide Market Size(US$)

CAGR 2025-2031

15.2%

Market Size,2031

USD 27.72

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 11.88 million

Market Forecast in 2031(Value)

US$ 27.72 million

CAGR

15.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 10.72 million in 2024 and is forecast to a readjusted size of US$ 27.72 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cosmetic Grade Nicotinamide Mononucleotide cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Cosmetic grade nicotinamide mononucleotide (NMN) is a niche but fast-growing part of both the NMN and cosmetic ingredients markets. In simple terms, NMN is a derivative of vitamin B3 and a direct precursor to NAD⁺, a molecule that cells use for energy, DNA repair, and many basic functions. When we talk about “cosmetic grade” NMN, we mean NMN that is produced and tested specifically for use on the skin, not for eating. Suppliers label it as “cosmetic grade, not food grade”, and sell it as a high-purity (usually ≥99%) active ingredient for use in creams, serums, masks and other skincare products.

From a market definition point of view, cosmetic grade NMN sits in the overlap of three areas: advanced cosmetic actives, NAD⁺-boosting “longevity” ingredients, and next-generation vitamin B3-type products. Many websites that sell cosmetic raw materials describe NMN as an “anti-aging superhero” ingredient that offers similar benefits to niacinamide (another B3 form) but with a stronger effect, such as helping moisturize the skin, strengthen the barrier, reduce wrinkles, brighten tone and improve hyperpigmentation. These claims are based on NMN’s biological role as a NAD⁺ precursor and on early research showing positive effects on skin cells and animal models, which has encouraged formulators to position NMN as a premium, science-based cosmetic active.

In 2024, global Cosmetic Grade Nicotinamide Mononucleotide production reached approximately 4.3 MT, with an average global market price of around US$ 2,479 per kg. The global single-line production capacity ranges from 0.5 to 1 MT per year. The industry's gross profit margin is approximately 30%-50%.

Market trends for cosmetic grade NMN are closely tied to the larger “longevity” and “science-based skincare” movements. Over the last few years, NAD⁺, NMN and related molecules have become popular in the wellness and longevity community, with large investments and heated scientific debates about how well these strategies actually work in humans. At the same time, beauty brands have been racing to add more “clinical” and “lab-tested” stories to their products. NAD⁺ skincare, which focuses on ingredients that maintain or raise NAD⁺ levels in skin cells, has begun to appear in fashion and lifestyle media as a new type of anti-aging approach. Cosmetic grade NMN fits directly into this trend, allowing brands to market themselves as sitting at the intersection of dermatology, anti-aging research and premium cosmetics.

Another strong driver is the need for differentiation in a very crowded anti-aging skincare market. Niacinamide, retinoids, vitamin C and peptides are now widely used and understood by consumers, which makes it harder for brands to stand out by using these ingredients alone. NMN, as a “next-generation B3” and NAD⁺ precursor, offers a fresh story. Suppliers highlight that NMN can offer all the typical niacinamide benefits (improving moisture, barrier function, tone and fine lines) with a “higher intensity” and extra support for cellular energy and repair. Because it is still relatively new, NMN gives brands the chance to launch hero products with unique messaging, higher price points, and a sense of cutting-edge innovation.

The rise of premium and dermocosmetic segments is also shaping this market. Many new NMN skincare launches position themselves as “clinical-grade,” “doctor-backed,” or “med-spa” style products, often combining NMN with other powerful actives such as peptides, hyaluronic acid, growth factors and retinoids. Cosmetic grade NMN is attractive in this context because it comes with high purity, clear documentation, and a technical data package that fits the expectations of dermatologists, aestheticians and advanced skincare consumers. Dermatology-style brands are also interested in NMN’s reported anti-inflammatory and barrier-supporting actions, which may be useful for sensitive, damaged or post-procedure skin.

This report aims to provide a comprehensive presentation of the global market for Cosmetic Grade Nicotinamide Mononucleotide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cosmetic Grade Nicotinamide Mononucleotide by region & country, by Type, and by Application.

The Cosmetic Grade Nicotinamide Mononucleotide market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cosmetic Grade Nicotinamide Mononucleotide.

MARKET SEGMENTATION

By Company

GeneHarbor
Herbalmax
Genex Formulas
EffePharm
Mirailab Bioscience
Bontac-bio
ABA Chemical
CELFULL

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Concentration≥98%
Concentration＜98%

Segment by Application

Skin Care Products
Facial Care Products
Hair Care Products

Segment by Category

Enzymatic Synthesis
Chemical Synthesis

Segment by Division

Direct-to-consumer Online
Offline Retail
Professional Channel

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cosmetic Grade Nicotinamide Mononucleotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Cosmetic Grade Nicotinamide Mononucleotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Cosmetic Grade Nicotinamide Mononucleotide in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Cosmetic Grade Nicotinamide Mononucleotide Product Introduction

1.2 Global Cosmetic Grade Nicotinamide Mononucleotide Market Size Forecast

1.2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value (2020-2031)

1.2.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (2020-2031)

1.2.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Price (2020-2031)

1.3 Cosmetic Grade Nicotinamide Mononucleotide Market Trends & Drivers

1.3.1 Cosmetic Grade Nicotinamide Mononucleotide Industry Trends

1.3.2 Cosmetic Grade Nicotinamide Mononucleotide Market Drivers & Opportunity

1.3.3 Cosmetic Grade Nicotinamide Mononucleotide Market Challenges

1.3.4 Cosmetic Grade Nicotinamide Mononucleotide Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Players Revenue Ranking (2024)

2.2 Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Company (2020-2025)

2.3 Global Cosmetic Grade Nicotinamide Mononucleotide Players Sales Volume Ranking (2024)

2.4 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Company Players (2020-2025)

2.5 Global Cosmetic Grade Nicotinamide Mononucleotide Average Price by Company (2020-2025)

2.6 Key Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Manufacturing Base and Headquarters

2.7 Key Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Cosmetic Grade Nicotinamide Mononucleotide

2.9 Cosmetic Grade Nicotinamide Mononucleotide Market Competitive Analysis

2.9.1 Cosmetic Grade Nicotinamide Mononucleotide Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Cosmetic Grade Nicotinamide Mononucleotide Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cosmetic Grade Nicotinamide Mononucleotide as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Concentration≥98%

3.1.2 Concentration＜98%

3.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type

3.2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, by Type (2020-2031)

3.2.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, by Type (%) (2020-2031)

3.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Type

3.3.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, by Type (2020-2031)

3.3.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, by Type (%) (2020-2031)

3.4 Global Cosmetic Grade Nicotinamide Mononucleotide Average Price by Type (2020-2031)

4 Segmentation by Production Method

4.1 Introduction by Production Method

4.1.1 Enzymatic Synthesis

4.1.2 Chemical Synthesis

4.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Production Method

4.2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Production Method (2020 VS 2024 VS 2031)

4.2.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, by Production Method (2020-2031)

4.2.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, by Production Method (%) (2020-2031)

4.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Production Method

4.3.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Production Method (2020 VS 2024 VS 2031)

4.3.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, by Production Method (2020-2031)

4.3.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, by Production Method (%) (2020-2031)

4.4 Global Cosmetic Grade Nicotinamide Mononucleotide Average Price by Production Method (2020-2031)

5 Segmentation by Sales Channel

5.1 Introduction by Sales Channel

5.1.1 Direct-to-consumer Online

5.1.2 Offline Retail

5.1.3 Professional Channel

5.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Sales Channel

5.2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Sales Channel (2020 VS 2024 VS 2031)

5.2.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, by Sales Channel (2020-2031)

5.2.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, by Sales Channel (%) (2020-2031)

5.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Sales Channel

5.3.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Sales Channel (2020 VS 2024 VS 2031)

5.3.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, by Sales Channel (2020-2031)

5.3.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, by Sales Channel (%) (2020-2031)

5.4 Global Cosmetic Grade Nicotinamide Mononucleotide Average Price by Sales Channel (2020-2031)

6 Segmentation by Application

6.1 Introduction by Application

6.1.1 Skin Care Products

6.1.2 Facial Care Products

6.1.3 Hair Care Products

6.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application

6.2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (2020 VS 2024 VS 2031)

6.2.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, by Application (2020-2031)

6.2.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, by Application (%) (2020-2031)

6.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Application

6.3.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Application (2020 VS 2024 VS 2031)

6.3.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, by Application (2020-2031)

6.3.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, by Application (%) (2020-2031)

6.4 Global Cosmetic Grade Nicotinamide Mononucleotide Average Price by Application (2020-2031)

7 Segmentation by Region

7.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region

7.1.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region: 2020 VS 2024 VS 2031

7.1.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (2020-2025)

7.1.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (2026-2031)

7.1.4 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (%), (2020-2031)

7.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region

7.2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region: 2020 VS 2024 VS 2031

7.2.2 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region (2020-2025)

7.2.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region (2026-2031)

7.2.4 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region (%), (2020-2031)

7.3 Global Cosmetic Grade Nicotinamide Mononucleotide Average Price by Region (2020-2031)

7.4 North America

7.4.1 North America Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

7.4.2 North America Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Country (%), 2024 VS 2031

7.5 Europe

7.5.1 Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

7.5.2 Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Country (%), 2024 VS 2031

7.6 Asia Pacific

7.6.1 Asia Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

7.6.2 Asia Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (%), 2024 VS 2031

7.7 South America

7.7.1 South America Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

7.7.2 South America Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Country (%), 2024 VS 2031

7.8 Middle East & Africa

7.8.1 Middle East & Africa Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

7.8.2 Middle East & Africa Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Country (%), 2024 VS 2031

8 Segmentation by Key Countries/Regions

8.1 Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Value Growth Trends, 2020 VS 2024 VS 2031

8.2 Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Value and Sales Volume

8.2.1 Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

8.2.2 Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, 2020-2031

8.3 United States

8.3.1 United States Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

8.3.2 United States Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

8.3.3 United States Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application, 2024 VS 2031

8.4 Europe

8.4.1 Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

8.4.2 Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

8.4.3 Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application, 2024 VS 2031

8.5 China

8.5.1 China Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

8.5.2 China Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

8.5.3 China Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application, 2024 VS 2031

8.6 Japan

8.6.1 Japan Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

8.6.2 Japan Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

8.6.3 Japan Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

8.7.2 South Korea Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

8.7.3 South Korea Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

8.8.2 Southeast Asia Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

8.8.3 Southeast Asia Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application, 2024 VS 2031

8.9 India

8.9.1 India Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020-2031

8.9.2 India Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

8.9.3 India Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application, 2024 VS 2031

9 Company Profiles

9.1 GeneHarbor

9.1.1 GeneHarbor Company Information

9.1.2 GeneHarbor Introduction and Business Overview

9.1.3 GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2025)

9.1.4 GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

9.1.5 GeneHarbor Recent Development

9.2 Herbalmax

9.2.1 Herbalmax Company Information

9.2.2 Herbalmax Introduction and Business Overview

9.2.3 Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2025)

9.2.4 Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

9.2.5 Herbalmax Recent Development

9.3 Genex Formulas

9.3.1 Genex Formulas Company Information

9.3.2 Genex Formulas Introduction and Business Overview

9.3.3 Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2025)

9.3.4 Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

9.3.5 Genex Formulas Recent Development

9.4 EffePharm

9.4.1 EffePharm Company Information

9.4.2 EffePharm Introduction and Business Overview

9.4.3 EffePharm Cosmetic Grade Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2025)

9.4.4 EffePharm Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

9.4.5 EffePharm Recent Development

9.5 Mirailab Bioscience

9.5.1 Mirailab Bioscience Company Information

9.5.2 Mirailab Bioscience Introduction and Business Overview

9.5.3 Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2025)

9.5.4 Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

9.5.5 Mirailab Bioscience Recent Development

9.6 Bontac-bio

9.6.1 Bontac-bio Company Information

9.6.2 Bontac-bio Introduction and Business Overview

9.6.3 Bontac-bio Cosmetic Grade Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2025)

9.6.4 Bontac-bio Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

9.6.5 Bontac-bio Recent Development

9.7 ABA Chemical

9.7.1 ABA Chemical Company Information

9.7.2 ABA Chemical Introduction and Business Overview

9.7.3 ABA Chemical Cosmetic Grade Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2025)

9.7.4 ABA Chemical Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

9.7.5 ABA Chemical Recent Development

9.8 CELFULL

9.8.1 CELFULL Company Information

9.8.2 CELFULL Introduction and Business Overview

9.8.3 CELFULL Cosmetic Grade Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2020-2025)

9.8.4 CELFULL Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

9.8.5 CELFULL Recent Development

10 Industry Chain Analysis

10.1 Cosmetic Grade Nicotinamide Mononucleotide Industrial Chain

10.2 Cosmetic Grade Nicotinamide Mononucleotide Upstream Analysis

10.2.1 Key Raw Materials

10.2.2 Raw Materials Key Suppliers

10.2.3 Manufacturing Cost Structure

10.3 Midstream Analysis

10.4 Downstream Analysis (Customers Analysis)

10.5 Sales Model and Sales Channels

10.5.1 Cosmetic Grade Nicotinamide Mononucleotide Sales Model

10.5.2 Sales Channel

10.5.3 Cosmetic Grade Nicotinamide Mononucleotide Distributors

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Cosmetic Grade Nicotinamide Mononucleotide Market Trends

Table 2. Cosmetic Grade Nicotinamide Mononucleotide Market Drivers & Opportunity

Table 3. Cosmetic Grade Nicotinamide Mononucleotide Market Challenges

Table 4. Cosmetic Grade Nicotinamide Mononucleotide Market Restraints

Table 5. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Market Share by Company (2020-2025)

Table 7. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Company (2020-2025) & (Tons)

Table 8. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Cosmetic Grade Nicotinamide Mononucleotide Price by Company (2020-2025) & (US$/Kg)

Table 10. Key Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Manufacturing Base and Headquarters

Table 11. Key Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Cosmetic Grade Nicotinamide Mononucleotide

Table 13. Global Cosmetic Grade Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cosmetic Grade Nicotinamide Mononucleotide as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Value by Type (2020-2025)

Table 20. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Value by Type (2026-2031)

Table 21. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Type (2020-2025) & (Tons)

Table 23. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Type (2026-2031) & (Tons)

Table 24. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Type (2020-2025) & (US$/Kg)

Table 27. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Type (2026-2031) & (US$/Kg)

Table 28. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Production Method: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Production Method (2020-2025) & (US$ Million)

Table 30. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Production Method (2026-2031) & (US$ Million)

Table 31. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Value by Production Method (2020-2025)

Table 32. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Value by Production Method (2026-2031)

Table 33. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Production Method: 2020 VS 2024 VS 2031 (Tons)

Table 34. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Production Method (2020-2025) & (Tons)

Table 35. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Production Method (2026-2031) & (Tons)

Table 36. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Volume by Production Method (2020-2025)

Table 37. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Volume by Production Method (2026-2031)

Table 38. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Production Method (2020-2025) & (US$/Kg)

Table 39. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Production Method (2026-2031) & (US$/Kg)

Table 40. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Sales Channel: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Sales Channel (2020-2025) & (US$ Million)

Table 42. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Sales Channel (2026-2031) & (US$ Million)

Table 43. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Value by Sales Channel (2020-2025)

Table 44. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Value by Sales Channel (2026-2031)

Table 45. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Sales Channel: 2020 VS 2024 VS 2031 (Tons)

Table 46. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Sales Channel (2020-2025) & (Tons)

Table 47. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Sales Channel (2026-2031) & (Tons)

Table 48. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Volume by Sales Channel (2020-2025)

Table 49. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Volume by Sales Channel (2026-2031)

Table 50. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Sales Channel (2020-2025) & (US$/Kg)

Table 51. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Sales Channel (2026-2031) & (US$/Kg)

Table 52. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 53. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (2020-2025) & (US$ Million)

Table 54. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (2026-2031) & (US$ Million)

Table 55. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Value by Application (2020-2025)

Table 56. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Value by Application (2026-2031)

Table 57. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)

Table 58. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Application (2020-2025) & (Tons)

Table 59. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Application (2026-2031) & (Tons)

Table 60. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Volume by Application (2020-2025)

Table 61. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share in Volume by Application (2026-2031)

Table 62. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Application (2020-2025) & (US$/Kg)

Table 63. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Application (2026-2031) & (US$/Kg)

Table 64. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 65. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (2020-2025) & (US$ Million)

Table 66. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (2026-2031) & (US$ Million)

Table 67. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (2020-2025) & (%)

Table 68. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (2026-2031) & (%)

Table 69. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region (Tons): 2020 VS 2024 VS 2031

Table 70. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region (2020-2025) & (Tons)

Table 71. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region (2026-2031) & (Tons)

Table 72. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region (2020-2025) & (%)

Table 73. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Region (2026-2031) & (%)

Table 74. Global Cosmetic Grade Nicotinamide Mononucleotide Average Price by Region (2020-2025) & (US$/Kg)

Table 75. Global Cosmetic Grade Nicotinamide Mononucleotide Average Price by Region (2026-2031) & (US$/Kg)

Table 76. Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 77. Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2025) & (US$ Million)

Table 78. Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2026-2031) & (US$ Million)

Table 79. Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, (2020-2025) & (Tons)

Table 80. Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Volume, (2026-2031) & (Tons)

Table 81. GeneHarbor Company Information

Table 82. GeneHarbor Introduction and Business Overview

Table 83. GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 84. GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

Table 85. GeneHarbor Recent Development

Table 86. Herbalmax Company Information

Table 87. Herbalmax Introduction and Business Overview

Table 88. Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 89. Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

Table 90. Herbalmax Recent Development

Table 91. Genex Formulas Company Information

Table 92. Genex Formulas Introduction and Business Overview

Table 93. Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 94. Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

Table 95. Genex Formulas Recent Development

Table 96. EffePharm Company Information

Table 97. EffePharm Introduction and Business Overview

Table 98. EffePharm Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 99. EffePharm Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

Table 100. EffePharm Recent Development

Table 101. Mirailab Bioscience Company Information

Table 102. Mirailab Bioscience Introduction and Business Overview

Table 103. Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 104. Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

Table 105. Mirailab Bioscience Recent Development

Table 106. Bontac-bio Company Information

Table 107. Bontac-bio Introduction and Business Overview

Table 108. Bontac-bio Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 109. Bontac-bio Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

Table 110. Bontac-bio Recent Development

Table 111. ABA Chemical Company Information

Table 112. ABA Chemical Introduction and Business Overview

Table 113. ABA Chemical Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 114. ABA Chemical Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

Table 115. ABA Chemical Recent Development

Table 116. CELFULL Company Information

Table 117. CELFULL Introduction and Business Overview

Table 118. CELFULL Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 119. CELFULL Cosmetic Grade Nicotinamide Mononucleotide Product Offerings

Table 120. CELFULL Recent Development

Table 121. Key Raw Materials Lists

Table 122. Raw Materials Key Suppliers Lists

Table 123. Cosmetic Grade Nicotinamide Mononucleotide Downstream Customers

Table 124. Cosmetic Grade Nicotinamide Mononucleotide Distributors List

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Cosmetic Grade Nicotinamide Mononucleotide Product Picture

Figure 2. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (2020-2031) & (Tons)

Figure 5. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Price (2020-2031) & (US$/Kg)

Figure 6. Cosmetic Grade Nicotinamide Mononucleotide Report Years Considered

Figure 7. Global Cosmetic Grade Nicotinamide Mononucleotide Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Cosmetic Grade Nicotinamide Mononucleotide Players Sales Volume Ranking (2024) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cosmetic Grade Nicotinamide Mononucleotide Revenue in 2024

Figure 10. Cosmetic Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Concentration≥98% Picture

Figure 12. Concentration＜98% Picture

Figure 13. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)

Figure 16. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Type (2020-2031) & (US$/Kg)

Figure 18. Enzymatic Synthesis Picture

Figure 19. Chemical Synthesis Picture

Figure 20. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Production Method (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value Market Share by Production Method, 2024 & 2031

Figure 22. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Production Method (2020 VS 2024 VS 2031) & (Tons)

Figure 23. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume Market Share by Production Method, 2024 & 2031

Figure 24. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Production Method (2020-2031) & (US$/Kg)

Figure 25. Direct-to-consumer Online Picture

Figure 26. Offline Retail Picture

Figure 27. Professional Channel Picture

Figure 28. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Sales Channel (2020 VS 2024 VS 2031) & (US$ Million)

Figure 29. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value Market Share by Sales Channel, 2024 & 2031

Figure 30. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Sales Channel (2020 VS 2024 VS 2031) & (Tons)

Figure 31. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume Market Share by Sales Channel, 2024 & 2031

Figure 32. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Sales Channel (2020-2031) & (US$/Kg)

Figure 33. Product Picture of Skin Care Products

Figure 34. Product Picture of Facial Care Products

Figure 35. Product Picture of Hair Care Products

Figure 36. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 37. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Value Market Share by Application, 2024 & 2031

Figure 38. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)

Figure 39. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Volume Market Share by Application, 2024 & 2031

Figure 40. Global Cosmetic Grade Nicotinamide Mononucleotide Price by Application (2020-2031) & (US$/Kg)

Figure 41. North America Cosmetic Grade Nicotinamide Mononucleotide Sales Value (2020-2031) & (US$ Million)

Figure 42. North America Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Country (%), 2024 VS 2031

Figure 43. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 44. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Country (%), 2024 VS 2031

Figure 45. Asia Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 46. Asia Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Region (%), 2024 VS 2031

Figure 47. South America Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 48. South America Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Country (%), 2024 VS 2031

Figure 49. Middle East & Africa Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Country (%), 2024 VS 2031

Figure 51. Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Value (%), (2020-2031)

Figure 52. Key Countries/Regions Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (%), (2020-2031)

Figure 53. United States Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 54. United States Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

Figure 55. United States Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (%), 2024 VS 2031

Figure 56. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 57. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

Figure 58. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (%), 2024 VS 2031

Figure 59. China Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 60. China Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

Figure 61. China Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (%), 2024 VS 2031

Figure 62. Japan Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 63. Japan Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

Figure 64. Japan Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (%), 2024 VS 2031

Figure 65. South Korea Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 66. South Korea Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

Figure 67. South Korea Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (%), 2024 VS 2031

Figure 68. Southeast Asia Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 69. Southeast Asia Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

Figure 70. Southeast Asia Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (%), 2024 VS 2031

Figure 71. India Cosmetic Grade Nicotinamide Mononucleotide Sales Value, (2020-2031) & (US$ Million)

Figure 72. India Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Type (%), 2024 VS 2031

Figure 73. India Cosmetic Grade Nicotinamide Mononucleotide Sales Value by Application (%), 2024 VS 2031

Figure 74. Cosmetic Grade Nicotinamide Mononucleotide Industrial Chain

Figure 75. Cosmetic Grade Nicotinamide Mononucleotide Manufacturing Cost Structure

Figure 76. Channels of Distribution (Direct Sales, and Distribution)

Figure 77. Bottom-up and Top-down Approaches for This Report

Figure 78. Data Triangulation

Figure 79. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 15.2% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

Which companies rank high in the global Cosmetic Grade Nicotinamide Mononucleotide market? shouQi

What is the annual compound growth rate of the global Cosmetic Grade Nicotinamide Mononucleotide market size from 2025 to 2031? shouQi

What was the global market size of Cosmetic Grade Nicotinamide Mononucleotide in 2031? shouQi

What was the global market size of Cosmetic Grade Nicotinamide Mononucleotide in 2025? shouQi

Related Reports

Cosmetic Grade Nicotinamide Mononucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 11.88 million in 2025 and is projected to reach US$ 31.51 million, growing at a CAGR of 15.2% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 105
USD 3950.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2026
The global Cosmetic Grade Nicotinamide Mononucleotide market was valued at US$ 11.88 million in 2025 and is anticipated to reach US$ 31.51 million by 2032, at a CAGR of 15.2% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 133
USD 2900.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cosmetic Grade Nicotinamide Mononucleotide market is projected to grow from US$ 10.72 million in 2024 to US$ 27.72 million by 2031, at a CAGR of 15.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-25
Pages: 145
USD 4900.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cosmetic Grade Nicotinamide Mononucleotide market size was US$ 10.72 million in 2024 and is forecast to a readjusted size of US$ 27.72 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.
Published Date: 2025-11-25
Pages: 76
USD 4250.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2025
The global market for Cosmetic Grade Nicotinamide Mononucleotide was valued at US$ 10.72 million in the year 2024 and is projected to reach a revised size of US$ 27.72 million by 2031, growing at a CAGR of 15.2% during the forecast period.
Published Date: 2025-11-25
Pages: 93
USD 2900.00
(Single User License)
Cosmetic Grade Nicotinamide Mononucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 264 million in 2024 and is forecast to a readjusted size of US$ 307 million by 2031 with a CAGR of 2.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 102
USD 3950.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Insights, Forecast to 2030
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
Published Date: 2024-04-14
Pages: 95
USD 4900.00
(Single User License)

Cosmetic Grade Nicotinamide Mononucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 11.88 million in 2025 and is projected to reach US$ 31.51 million, growing at a CAGR of 15.2% from 2026 to 2032.
Published: 2026-02-02
Pages: 105
USD 3950.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2026
The global Cosmetic Grade Nicotinamide Mononucleotide market was valued at US$ 11.88 million in 2025 and is anticipated to reach US$ 31.51 million by 2032, at a CAGR of 15.2% from 2026 to 2032.
Published: 2026-02-02
Pages: 133
USD 2900.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cosmetic Grade Nicotinamide Mononucleotide market is projected to grow from US$ 10.72 million in 2024 to US$ 27.72 million by 2031, at a CAGR of 15.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-25
Pages: 145
USD 4900.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cosmetic Grade Nicotinamide Mononucleotide market size was US$ 10.72 million in 2024 and is forecast to a readjusted size of US$ 27.72 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.
Published: 2025-11-25
Pages: 76
USD 4250.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2025
The global market for Cosmetic Grade Nicotinamide Mononucleotide was valued at US$ 10.72 million in the year 2024 and is projected to reach a revised size of US$ 27.72 million by 2031, growing at a CAGR of 15.2% during the forecast period.
Published: 2025-11-25
Pages: 93
USD 2900.00 (Single User License)
Cosmetic Grade Nicotinamide Mononucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 264 million in 2024 and is forecast to a readjusted size of US$ 307 million by 2031 with a CAGR of 2.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 102
USD 3950.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Insights, Forecast to 2030
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
Published: 2024-04-14
Pages: 95
USD 4900.00 (Single User License)